Search results
Earnings call: Moleculin Biotech optimistic on Annamycin's future By Investing.com
Investing.com· 5 hours agoMoleculin Biotech, Inc. (NASDAQ:MBRX), in its first quarter 2024 earnings call, highlighted...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Motley Fool via Yahoo Finance· 1 day agoPharmaceuticals repeat the success it had in CF with inaxaplin? Maybe, but the company's prospects...
Cathie Wood's ARK Invest's Third-Largest Holding Is this Little Known Biotech Company Harnessing AI...
Homenewshere.com· 6 hours agoCathie Wood's ARK Invest has been buying shares of Recursion Pharmaceuticals, a biotech company...
AI, biotech seen transforming healthcare
China Daily· 1 hour agoNew quality productive forces, represented by artificial intelligence and other digital technologies, are shaping China's healthcare sector, likely cultivating the next paradigm shift, industry ...
Biotech Slumps Despite 'Pristine' Results For Bristol-Rivaling Heart Drug
Investor's Business Daily· 7 hours agoThe company tested its drug, aficamten, in patients with obstructive hypertrophic cardiomyopathy, or...
How Viking Therapeutics Stock Could 30x
The Motley Fool via AOL· 14 hours agoThe biotech's shares have stormed higher by almost 300% year to date on the back of its midstage weight-loss candidate, VK2735. The...reach a staggering...
NewVale, an unorthodox investment firm, sets out to support biotech’s ‘infrastructure’
BioPharma Dive via Yahoo Finance· 21 hours agoThe firm, which closed a $167 million fund, aims to fill a “crucial gap” by growing the companies...
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Zacks via Yahoo Finance· 17 hours agoThe Dynamic Biotech & Genome Intellidex Index seeks to provide capital appreciation by thoroughly...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 4 days agoZacks Rank and Stocks to Consider Catalyst currently carries a Zacks Rank #3 (Hold). Some...
Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
Zacks via Yahoo Finance· 7 days agoIndustry: Biotech Link: https://www.zacks.com/commentary/2268804/5-biotech...
